Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...

The global biologics contract development and manufacturing organization (cdmo) market size is estimated to grow by USD 16.32 ...

Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...

‘Chronos-PD’ is looking for biological signals that could indicate ... tools and disease-modifying therapiesPart of broad Grifols program to find disease-revealing clues in more than 100 ...

“We believe we can help consumers move from reactive to proactive ageing, with individualised insights about their biological age ... at Bayer Consumer Health. Grifols has been awarded a $ ...

Spanish pharma Grifols is leveraging its massive collection of plasma samples to look for early biomarkers of Parkinson’s disease (PD) thanks to a $21 million grant from the Michael J.

Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify plasma-based ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF ...

A trade group representing thousands of football coaches at all levels of the sport has turned to K Street for help squeezing ...